Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris The
Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company
PR Newswire
NEW YORK, March 22, 2019
NEW YORK, March 22, 2019 /PRNewswire/ --
Amarin Corporation plc (AMRN)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amarin administered an active agent to their placebo group during the Vascepa trial, which consequently exaggerated the efficacy of Vascepa.
If you are AMRN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Clementia Pharmaceuticals Inc. (CMTA)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of CMTA to Ipsen for $25 per share.
If you are a CMTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
CVS Health Corporation (CVS)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with CVS' lowered stock value due to poor results from the company's 2015 acquisition of Omnicare, Inc.
If you are a CVS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Diplomat Pharmacy, Inc. (DPLO)
Lifshitz & Miller announces an investigation into possible securities laws violations in connection with DPLO's announcement that it was delaying its financial results and will need to record a non-cash impairment charge.
If you are a DPLO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
GTx, Inc. (GTXI)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the merger of GTx with Oncternal Therapeutics.
If you are a GTx investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Mutli-Color Corporation (LABL)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of LABL to Platinum Equity LLC for $50.00 per share.
If you are a LABL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Osiris Therapeutics, Inc. (OSIR)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the sale of OSIR to Smith & Nephew for $19.00 per share.
If you are a OSIR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
The Kraft Heinz Company (KHC)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with a subpoena KHC received from the SEC regarding its accounting practices.
If you are a KHC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING.© 2019 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
View original content:SOURCE Lifshitz & Miller Law Firm
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.